Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-17-001988
Filing Date
2017-03-24
Accepted
2017-03-24 17:30:18
Documents
14
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2231510z10-k.htm 10-K 1410814
2 EX-10.7 a2231510zex-10_7.htm EX-10.7 28517
3 EX-10.8 a2231510zex-10_8.htm EX-10.8 26712
4 EX-10.9 a2231510zex-10_9.htm EX-10.9 20980
5 EX-10.10 a2231510zex-10_10.htm EX-10.10 22393
6 EX-23.1 a2231510zex-23_1.htm EX-23.1 2630
7 EX-31.1 a2231510zex-31_1.htm EX-31.1 8074
8 EX-31.2 a2231510zex-31_2.htm EX-31.2 8111
9 EX-32.1 a2231510zex-32_1.htm EX-32.1 4874
10 G550372.JPG g550372.jpg GRAPHIC 16936
11 G41816.JPG g41816.jpg GRAPHIC 15810
12 G319073.JPG g319073.jpg GRAPHIC 15629
13 G661436.JPG g661436.jpg GRAPHIC 22206
14 G574549.JPG g574549.jpg GRAPHIC 24962
  Complete submission text file 0001047469-17-001988.txt   1666361
Mailing Address 225 2ND AVENUE WALTHAM MA 02451
Business Address 225 2ND AVENUE WALTHAM MA 02451 781-663-4400
Bioverativ Inc. (Filer) CIK: 0001681689 (see all company filings)

EIN.: 813461310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37859 | Film No.: 17713673
SIC: 2834 Pharmaceutical Preparations